Literature DB >> 11871591

Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese.

H Fumimoto1, K Kobayashi, C H Chang, S Eremenco, Y Fujiki, S Uemura, Y Ohashi, S Kudoh.   

Abstract

The General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G) was developed in an English-speaking culture (USA). To determine if FACT-G could be used in Japan, a cross-cultural validation was performed. The Japanese version was created through an iterative forward-backward translation sequence used throughout the FACT multi-lingual translation project. In evaluating psychometric testing, its construct validity was investigated by factor analysis and multi-trait scaling analysis. Clinical validity was estimated by known-groups comparison using stage, performance score (PS) and patient location, and validated longitudinally by PS. The FACT-G (version 3) was given to 180 patients with lung cancer. Analyses showed that the scales of Physical, Functional, Emotional Well-Being, and Relationship with Doctors were constructively valid in Japan. Japanese patients felt that familial relationships were different than those with friends and neighbors, indicating that the Social/Family Well-Being scale needed cultural adaptation. Two items concerning coping with illness and acceptance of illness did not load predictably onto their respective scales and were considered to be cross-culturally problematic. However, clinical validity demonstrated its sensitivity. Japanese version 4 has been improved to address the weakness in an attempt to become an instrument that is applicable across cultures.

Entities:  

Mesh:

Year:  2001        PMID: 11871591     DOI: 10.1023/a:1013851216181

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  10 in total

1.  The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.

Authors:  S Kaasa; K Bjordal; N Aaronson; T Moum; E Wist; S Hagen; A Kvikstad
Journal:  Eur J Cancer       Date:  1995-12       Impact factor: 9.162

2.  A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.

Authors:  K Kobayashi; F Takeda; S Teramukai; I Gotoh; H Sakai; S Yoneda; Y Noguchi; H Ogasawara; K Yoshida
Journal:  Eur J Cancer       Date:  1998-05       Impact factor: 9.162

3.  Developing instruments for cross-cultural psychiatric research.

Authors:  J A Flaherty; F M Gaviria; D Pathak; T Mitchell; R Wintrob; J A Richman; S Birz
Journal:  J Nerv Ment Dis       Date:  1988-05       Impact factor: 2.254

4.  Culturally sensitive family assessment: an evaluation of the family assessment device used with Hawaiian-American and Japanese-American families.

Authors:  T M Morris
Journal:  Fam Process       Date:  1990-03

5.  Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample.

Authors:  P Winstead-Fry; A Schultz
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

6.  Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system.

Authors:  A E Bonomi; D F Cella; E A Hahn; K Bjordal; B Sperner-Unterweger; L Gangeri; B Bergman; J Willems-Groot; P Hanquet; R Zittoun
Journal:  Qual Life Res       Date:  1996-06       Impact factor: 4.147

7.  Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales.

Authors:  L Lent; E Hahn; S Eremenco; K Webster; D Cella
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

8.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

9.  The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.

Authors:  M A Sprangers; A Cull; K Bjordal; M Groenvold; N K Aaronson
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

10.  Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

Authors:  D F Cella; A E Bonomi; S R Lloyd; D S Tulsky; E Kaplan; P Bonomi
Journal:  Lung Cancer       Date:  1995-06       Impact factor: 5.705

  10 in total
  28 in total

1.  Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia.

Authors:  Ricardo Sánchez; Monica Ballesteros; Benjamin J Arnold
Journal:  Qual Life Res       Date:  2010-10-30       Impact factor: 4.147

2.  Korean translation and validation of the functional assessment of cancer therapy-lung (FACT-L) version 4.

Authors:  Heejung Yoo; Cheolwon Suh; Sangwee Kim; Sonya Eremenco; Hwan Kim; Seongyoon Kim
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

Review 3.  Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments.

Authors:  Satoshi Morita; Adrian A Kaptein; Akira Tsuburaya; Yasuhiro Kodera; Takanori Matsui; Junichi Sakamoto
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

4.  Measuring quality of life among cervical cancer survivors: preliminary assessment of instrumentation validity in a cross-cultural study.

Authors:  Kimlin T Ashing-Giwa; Jinsook Kim; Judith S Tejero
Journal:  Qual Life Res       Date:  2007-11-16       Impact factor: 4.147

Review 5.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

6.  Validation of the care notebook for measuring physical, mental and life well-being of patients with cancer.

Authors:  Kunihiko Kobayashi; Joseph Green; Mari Shimonagayoshi; Noriaki Kanemoto; Ryo Kasai; Yoichi Itoh; Yuki Fujiki; Yasuo Ohashi; Carolyn Gotay; Shoji Kudoh
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

7.  Which quality of life instruments are preferred by cancer patients in Japan? Comparison of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Functional Assessment of Cancer Therapy-General.

Authors:  Kazuki Sato; Megumi Shimizu; Mitsunori Miyashita
Journal:  Support Care Cancer       Date:  2014-05-28       Impact factor: 3.603

8.  Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale.

Authors:  Maya Kurita; Kojiro Shimozuma; Satoshi Morita; Yuki Fujiki; Kenichi Ishizawa; Hisae Eguchi; Yuko Saito; Nobuko Ushirozawa; Izumi Wasada; Yasuo Ohashi; Kenji Eguchi
Journal:  Support Care Cancer       Date:  2006-10-07       Impact factor: 3.603

9.  Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial.

Authors:  Kazunari Misawa; Michitaka Fujiwara; Masahiko Ando; Seiji Ito; Yoshinari Mochizuki; Yuichi Ito; Eiji Onishi; Kiyoshi Ishigure; Yuki Morioka; Tsunenobu Takase; Takuya Watanabe; Yoshitaka Yamamura; Satoshi Morita; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2014-05-07       Impact factor: 7.370

10.  The Functional Assessment of Cancer Therapy-Prostate (FACT-P) scales in men with prostate cancer: reliability and validity of the Korean version.

Authors:  Jeong Hee Hong; Seong Soo Jeon; Hyun Moo Lee; Yoon Ho Choi; Seonwoo Kim; Han Yong Choi
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.